Transient over-expression of Calpain-3 (variant hMp84) impairs cell proliferation and leads to cell detachment in A375 melanoma cells. by Daniele Moretti (379766)

hMp84 induces DNA damage and oxidative alterations of phospholipids in A375 melanoma cells, by stimulating the formation of Reactive Oxygen Species (ROS). by Daniele Moretti (379766)

Methane Diffusion in a Flexible Kerogen Matrix by Amaël Obliger (3107358)

“…However, in the usual frozen matrix approximation, diffusivity decreases with increasing fluid loading, as evidenced by a loss of free volume, accounting for adsorption-induced swelling that gives rise to an increase in free volume and, hence, in diffusivity. …”

Video example of a boundary vector cell. by Lear Cohen (15353793)

Video example of a boundary vector cell. by Lear Cohen (15353793)

Video example of a boundary vector cell. by Lear Cohen (15353793)

The N-terminus of FBG1 is required for the degradation, but not binding of A1AT-Z. by John H. Wen (785980)

FBG1-mediated degradation of A1AT-Z occurs through the proteasome. by John H. Wen (785980)

FBG1 knockout increases A1AT-Z accumulation in the mouse liver. by John H. Wen (785980)

H/D exchange results for free and complexed LmnA with AIMP3. by Yeqing Tao (4348336)

“…<p>ARDD for LmnA is calculated as for AIMP3. Top: LmnA shows decreased D-uptake for segment 203–209 (641–647) upon binding AIMP3. …”

Intracellular accumulation and glucuronidation of β-lap in colon cancer cells. by Huiying Liu (148261)

“…(A) Intracellular β-lap level in HCT116 is much higher than in HT29 cells; (B) Propofol or siRNA pretreatment lead to intracellular accumulation of β-lap in HT29 cells; (C) Propofol or siRNA pretreatment decreases intracellular M2 level in HT29 cells; (D) Propofol or siRNA pretreatment decreases M2 level in HT29 cell culture medium. …”

Input values example for a numerical problem. by Pavel Kodytek (10140509)

“…Software development and testing are time-consuming processes, and the current market faces a lack of specialized experts. Introducing automation to this field could, therefore, improve software engineers’ common workflow and decrease the time to market. …”

Results of imaging evaluation of the three experimental groups. by Florent Guérin (746358)

Spatial resolution bar pattern comparison: (a) FBP (sharp kernel) and (b) TV with high fidelity term image with proposed model (111) are displayed in HU. by Synho Do (659417)

Image_1_Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis.jpeg by Selma Olsson Åkefeldt (11982299)

“…Conversely, neutralizing anti-IL-17A antibodies decreased BCL2A1 expression, the downregulation of which lowered the survival rate of Mo-DCs from LCH patients. …”

Image_2_Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis.jpeg by Selma Olsson Åkefeldt (11982299)

“…Conversely, neutralizing anti-IL-17A antibodies decreased BCL2A1 expression, the downregulation of which lowered the survival rate of Mo-DCs from LCH patients. …”

Glucuronidation of β-lap in HT29 cell S9 fractions. by Huiying Liu (148261)

“…<p>HT29 cells S9 were incubated with β-lap according to the details in methods. (A) A typical Michaelis-Menten kinetics of β-lap glucuronidation in HT29 cells S9 fractions; (B) UGT1A siRNA treated HT29 cells S9 fractions significantly decreases β-lap glucuronidation; (C) Inhibitory potency of propofol on β-lap glucuronidation in HT29 cell S9 fractions. …”

Molecular Mechanism of GmSNE3 Ubiquitin Ligase-Mediated Inhibition of Soybean Nodulation by Halosulfuron Methyl by Yuanfu Li (18816921)

Subjects:

H/D exchange results for free and complexed AIMP3 with LmnA. by Yeqing Tao (4348336)

“…Peptide regions with significant deuterium uptake differences are mapped onto the crystal structure. Top: AIMP3 shows decreases in D-uptake for segments 91–96 and 134–152 upon binding to LmnA, consistent with the binding interface between AIMP3 and LmnA. …”

Distribution of IQ score (A) and years of education completed (B) by treatment status (A, B) and sex (B). by Joanna P. MacEwan (3924404)